EATRIS is running a series of webinars in the fall of this year, looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation). These webinars are developed in close collaboration with other Research Infrastructures (EU-OPENSCREEN, INFRAFRONTIER, BBMRI, ECRIN) and initiatives such as Translation Together.
The webinars will be brought to you by experts in the field and include an audience Q&A session during which attendees can ask questions at the end of the lecture. All webinars will be recorded and available for later viewing.
For more information and registration: https://eatris.eu/insights/webinar-series-quality-reproducibility-issues-drug-development/
Schedule
SESSION 1: NOVEMBER 8th - 15.00 CET
The Relevance of Reproducibility for Drug Development: An Introduction
by Anton Ussi (EATRIS),Leonard Freedman (Frederick National Laboratory for Cancer Research) and Andreas Scherer (FIMM)
SESSION 2: NOVEMBER 19th – 15:00 CET
Quality in high-throughput screening
by Matthew Hall (NIH NCATS) and Wolfgang Fecke (EU-OPENSCREEN)
SESSION 3: DECEMBER 13th – 14:00 CET
Reproducibility in preclinical and animal experimentation
by Björn Gerlach (PAASP) and Michael Raess (INFRAFRONTIER)
SESSION 4: DECEMBER 17th – 14:00 CET
Preanalytical validation and quality systems in biobanking
by Monica Marchese (IBBL) and Andrea Wutte (BBMRI-ERIC)
SESSION 5: JANUARY 14th - 15:00 CET
Technology Platform reproducibility
by Weida Tong (NCTR/FDA) and Marian Hajduch (IMTM)
SESSION 6: FEBRUARY 18th – 14:00 CET
Quality and reproducibility issues related to clinical development
by Christine Toneatti (ECRIN)